Rezultati pretrage - Cecilia M. Fenoglio‐Preiser

  • Prikaz rezultata 1 – 10 od 10
Detaljiziraj rezultate
  1. 1
    The future of prognostic factors in outcome prediction for patients with cancer

    The future of prognostic factors in outcome prediction for patients with cancer od L P Fielding, Cecilia M. Fenoglio‐Preiser, Laurence S. Freedman

    Izdano 1992
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential

    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential od S. Coverlizza, Mauro Risio, Andrea Ferrari, Cecilia M. Fenoglio‐Preiser, F. P. Rossini

    Izdano 1989
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  3. 3
    American Joint Committee on Cancer prognostic factors consensus conference

    American Joint Committee on Cancer prognostic factors consensus conference od Carolyn C. Compton, Cecilia M. Fenoglio‐Preiser, Norman M. Pettigrew, L P Fielding

    Izdano 2000
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  4. 4
    Serrated Polyps of the Large Intestine

    Serrated Polyps of the Large Intestine od Dale C. Snover, Jeremy R. Jass, Cecilia M. Fenoglio‐Preiser, Kenneth P. Batts

    Izdano 2005
    Preuzmi cijeli tekst
    Carta
    Spremi u popis
    Spremljeno u:
  5. 5
    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps

    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps od Won Chul Lee, Alfred I. Neugut, Gail Garbowski, Kenneth A. Forde, Michael R. Treat, J. Ways, Cecilia M. Fenoglio‐Preiser

    Izdano 1993
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer od Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression

    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression od Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy

    Izdano 2007
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 od Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese

    Izdano 2006
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation od Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... od Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: